<DOC>
	<DOCNO>NCT03069638</DOCNO>
	<brief_summary>The main objective study evaluate effectivity intranasal dexmedetomidine sedation intra-articular injection therapy . Intranasal dexmedetomidine compare dinitrous oxide ( N2O ) already prove safe effective sedation method painful procedure pediatric patient . In early study median VAS intra-articular corticosteroid injection patient receive nitrous oxide 3 ( Uziel et al 2008 ) . Study hypothesis intranasal dexmedetomidine sedation VAS pain level 1 unit lower .</brief_summary>
	<brief_title>Intranasal Dexmedetomidine Sedation During Intra-articular Joint Injections Pediatric Population</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Hypnotics Sedatives</mesh_term>
	<mesh_term>Nitrous Oxide</mesh_term>
	<criteria>Patient age age 1year 18 year A joint inflammation 15 joint need intraarticular corticosteroid injection diagnose pediatric rheumatologist Patients age 1year age 18years exclude well patient need injection therapy 5 joint .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>sedation</keyword>
	<keyword>pediatrics</keyword>
	<keyword>intranasal sedation</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>dinitrous oxide</keyword>
	<keyword>intra-articular joint injection</keyword>
</DOC>